Sanofi to Buy Medley

Medley specializes in generic treatments

French pharmaceutical group Sanofi Aventis said on April 9 it will acquire Brazil's Medley, a specialist in generic treatments, for $665 million (500 million euros.)

Medley, ranked third in Brazil, posted 2008 sales of some 150 million euros, two thirds of which were accounted for by generic drugs -- those on which patents have lapsed.

"This acquisition will allow Sanofi Aventis to strengthen its number one position in Brazil," the company said.

Copyright Agence France-Presse, 2009

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.